The China National Medical Products Administration (NMPA) has granted expanded approval to MSD's GARDASIL, [Human ...
Human Papillomavirus (HPV) is a widespread sexually transmitted infection, affecting nearly 80 percent of sexually active ...
Approximately 11,500 new cases of cervical cancer are diagnosed each year and, sadly, roughly 4,000 women will succumb to the disease, according to the Centers for Disease Control and Prevention. But ...
HPV-16 E7 is under clinical development by Gilead Sciences and currently in Phase II for Oropharyngeal Cancer.
The recipient in Changsha, the capital of Hunan province, became the first man on the Chinese mainland to receive the HPV ...
The HPV vaccine, Gardasil, has gained approval for additional indications from China's National Medical Products ...
GARDASIL is the first HPV vaccine approved for the prevention of certain HPV-related cancers and diseases in Chinese males ...